Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02472561 · ClinicalTrials.gov registry record · NA
Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02472561 is a NA study that has completed, run by Duke University. The registered enrollment target is 22 participants.
The verdict
NCT02472561, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effects that a three month lifestyle-based mobile health (mHealth) peripheral artery disease (PAD) prevention program will have on improving physical activity, fitness, important PAD risk factors and quality of life (QOL) in patients with PAD. By testing a novel mHealth intervention focused on lifestyle modification, this trial will address a critical evidence gap in the care of PAD patients. PAD patients are not eligible for cardiac rehabilitation and therefore struggle with unhealthy lifestyles, and these patients currently have no lifestyle-based care strategies to help them. The results of this study have the potential to lead to new sustainable and resource-efficient, lifestyle-based preventive care strategies for patients with stable PAD.
Interventions
- OTHER Fitbit Physical Activity Monitor
- OTHER mHealth Glucometer
- OTHER mHealth Blood Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-11-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02472561
The ClinicalTrials.gov registry entry for NCT02472561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fitbit Physical Activity Monitor is the first listed.
NCT02472561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02472561 about?
NCT02472561 is a clinical study titled "Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)". The purpose of this study is to understand the effects that a three month lifestyle-based mobile health (mHealth) peripheral artery disease (PAD) prevention program will have on improving physical activity, fitness, important PAD risk factors and quality of life (QOL) in patients with PAD. By testi...
What is the current status of trial NCT02472561?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-07. Estimated completion is 2017-11-07.
What interventions are being tested in trial NCT02472561?
The interventions under investigation include: Fitbit Physical Activity Monitor (OTHER), mHealth Glucometer (OTHER), mHealth Blood Pressure (OTHER).
Who is sponsoring clinical trial NCT02472561?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.